IL6, interleukin 6, 3569

N. diseases: 270; N. variants: 4
Disease: Prostatic Neoplasms ×
Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Therapeutic group CTD_human Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition. 25970160 2015
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker group CTD_human Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition. 25970160 2015
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Therapeutic group CTD_human Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. 19011039 2009
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Therapeutic group CTD_human Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2. 19240160 2009
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker group CTD_human Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. 19011039 2009
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker group CTD_human Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2. 19240160 2009
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker group CTD_human p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion. 17196171 2007
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Therapeutic group CTD_human p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion. 17196171 2007
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker group CTD_human Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor. 15672864 2004
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Therapeutic group CTD_human Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor. 15672864 2004